Core Viewpoint - Targeting age-related LINE-1 activation can alleviate cardiac aging, highlighting its potential as a therapeutic target for age-related cardiac dysfunction [4]. Group 1: Research Findings - The study indicates that the expression of LINE-1 in the heart increases with age [7]. - Researchers created heart-specific Mov10 gene knockout mice, which could not suppress LINE-1 expression, leading to LINE-1 de-repression, cardiac dysfunction, and early cardiac aging by three months of age [7]. - Activation of the cGAS-STING pathway was observed in these knockout mice, suggesting a link between LINE-1 and cardiac aging [7]. Group 2: Therapeutic Implications - The use of Lamivudine (3TC), a reverse transcriptase inhibitor, and H-151, which inhibits STING, both suppressed cGAS-STING activation and alleviated aging in new muscle cells from Mov10 knockout mice [7]. - Both inhibitors improved cardiac function in naturally aged mice and reduced cardiac inflammation and aging phenotypes [7]. - These findings suggest that LINE-1 and its downstream effectors could be potential targets for treating age-related cardiac dysfunction [7].